{"id":358,"date":"2022-07-24T23:34:40","date_gmt":"2022-07-24T23:34:40","guid":{"rendered":"http:\/\/wmtc2006.com\/?p=358"},"modified":"2022-07-24T23:34:40","modified_gmt":"2022-07-24T23:34:40","slug":"although-neither-sex-nor-age-were-significantly-associated-with-disease-outcome-in-any-model-for-denv-3-we-ran-a-paired-case-control-analysis-matching-on-these-variables","status":"publish","type":"post","link":"https:\/\/wmtc2006.com\/?p=358","title":{"rendered":"\ufeffAlthough neither sex nor age were significantly associated with disease outcome in any model for DENV-3, we ran a paired case-control analysis, matching on these variables"},"content":{"rendered":"<p>\ufeffAlthough neither sex nor age were significantly associated with disease outcome in any model for DENV-3, we ran a paired case-control analysis, matching on these variables. a 4-fold rise in IgM titer between acute and convalescent samples (18%). Although symptomatic illness was more common with naive or monotypic serostatus than with multitypic serostatus (Table ?(Table2),2), the latter accounted for 45% of all detected cases of disease due to DENV-4. Overall, the ratio of apparent to inapparent DENV-4 infections was 1:9. Estimates of Disease Risk In a multivariable model, contamination history and Lck Inhibitor participant age were significantly associated with risk of disease due to DENV-4 contamination (Table ?(Table33 and Supplementary Tables 1 and 2). Monotypic DENV-1 antibodies were associated with reduced odds of disease, whereas monotypic DENV-2 or DENV-3 antibodies were not (Table ?(Table3).3). Disease risk was significantly reduced for individuals with multitypic serostatus (OR, 0.22; 95% CI, .13C.38), with additional protective effects beyond that of DENV-1 antibodies alone (= .0069 by the <a href=\"https:\/\/www.adooq.com\/lck-inhibitor.html\">Lck Inhibitor<\/a> Wald test). Disease risk appeared to vary nonlinearly with age (Physique ?(Figure2),2), with the highest risk between 25 and 30 years of age. As with DENV-3, when city block was included as a random effect, no impact on the relationship between age, serostatus, and disease was observed. Matched-pairs case-control analysis also showed that the presence of antibodies to 2 DENV serotypes was associated with reduced disease, independent of age and sex (OR, 0.2; 95% CI, .086C.41). Open in a separate window Physique 2. Predicted risk of disease due to contamination with dengue computer virus serotype 4 (DENV-4), as a function of age and serostatus. Naive and monotypic exposures were combined because they were statistically indistinguishable ( .05). Curves were estimated from the best fit model (Table 3) and plotted with standard error of the mean. DISCUSSION Disease in Iquitos was significantly reduced among individuals with postsecondary DENV-3 and DENV-4 infections. Relative to average disease rates during primary and secondary infections, the incidence among postsecondary infections was reduced by 93% for DENV-3 Lck Inhibitor and 64% for DENV-4, even though contamination rates were not reduced among people with prior exposures to DENV. To our knowledge, this is the first population-based evidence quantifying a cumulative protective effect of heterologous DENV neutralizing antibodies against disease, which has been hypothesized for 40 years [36]. Previous studies investigating cross-protection in sequential infections have provided evidence for a short period of protection against classic dengue fever [37] and long-term protection against severe disease in third and fourth infections [10]. Although we did not attempt to estimate a short-term effect and we did not observe any cases of severe dengue, we were able to show that the effect of heterologous antibody was cumulative, resulting in a reduced incidence of disease during postsecondary contamination with DENV-3 or DENV-4. Cross-protection was not uniform across serotypes. People with DENV-1 neutralizing antibodies were less likely to develop disease, pointing to an epidemiologically important role of the sequence of infecting serotypes in determining clinical outcome [9, 29, 38C40]. This obtaining, however, is usually discordant <a href=\"http:\/\/www.digitalhistory.uh.edu\/database\/article_display.cfm?HHID=105\">Rabbit Polyclonal to SLC6A15<\/a> with the observation made in Cuba that infections with DENV-3 were more pathogenic in the presence of preexisting DENV-1 antibody than with DENV-2 antibody [41], which underscores the need to exercise caution in generalizing epidemiological observations between different populations. Previously, cross-reactive DENV-1 antibodies were hypothesized to protect against severe disease during secondary contamination with American genotype DENV-2 [29]. Together, these data indicate that, in the context of the study populace in Iquitos, DENV-1 antibodies may be broadly cross-protective but that antibodies to American DENV-2 and genotype III of DENV-3 are not, although they do contribute to a cumulative effect of reduced disease. In contrast to reduced rates of Lck Inhibitor disease, contamination rates were higher among people with neutralizing antibody to 2 DENV serotypes. Studies in Cuba of 1981 and 1997 dengue epidemics also found higher contamination rates in individuals with prior DENV exposure [42, 43], which the authors hypothesized was due to household-level heterogeneities in mosquito populations. In Iquitos, we have observed consistent spatial variation in populace densities [44] that correlates well with patterns of seroprevalence on broad spatial scales [19, 30] and supports the premise that seroconversion rates are attributable at least in part to variation in individual exposure to mosquito bites..<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\ufeffAlthough neither sex nor age were significantly associated with disease outcome in any model for DENV-3, we ran a paired case-control analysis, matching on these [&#8230;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[45],"tags":[],"class_list":["post-358","post","type-post","status-publish","format-standard","hentry","category-hydroxytryptamine-5-transporters"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>\ufeffAlthough neither sex nor age were significantly associated with disease outcome in any model for DENV-3, we ran a paired case-control analysis, matching on these variables - Discovery and characterization of Histamine-2 Receptor Antagonists<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/wmtc2006.com\/?p=358\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\ufeffAlthough neither sex nor age were significantly associated with disease outcome in any model for DENV-3, we ran a paired case-control analysis, matching on these variables - Discovery and characterization of Histamine-2 Receptor Antagonists\" \/>\n<meta property=\"og:description\" content=\"\ufeffAlthough neither sex nor age were significantly associated with disease outcome in any model for DENV-3, we ran a paired case-control analysis, matching on these [...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/wmtc2006.com\/?p=358\" \/>\n<meta property=\"og:site_name\" content=\"Discovery and characterization of Histamine-2 Receptor Antagonists\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-24T23:34:40+00:00\" \/>\n<meta name=\"author\" content=\"wpadmin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpadmin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/wmtc2006.com\\\/?p=358#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/wmtc2006.com\\\/?p=358\"},\"author\":{\"name\":\"wpadmin\",\"@id\":\"http:\\\/\\\/wmtc2006.com\\\/#\\\/schema\\\/person\\\/5a1d916d8ed9c89b34ac45c96f81e776\"},\"headline\":\"\ufeffAlthough neither sex nor age were significantly associated with disease outcome in any model for DENV-3, we ran a paired case-control analysis, matching on these variables\",\"datePublished\":\"2022-07-24T23:34:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/wmtc2006.com\\\/?p=358\"},\"wordCount\":705,\"articleSection\":[\"Hydroxytryptamine, 5- Transporters\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/wmtc2006.com\\\/?p=358\",\"url\":\"https:\\\/\\\/wmtc2006.com\\\/?p=358\",\"name\":\"\ufeffAlthough neither sex nor age were significantly associated with disease outcome in any model for DENV-3, we ran a paired case-control analysis, matching on these variables - Discovery and characterization of Histamine-2 Receptor Antagonists\",\"isPartOf\":{\"@id\":\"http:\\\/\\\/wmtc2006.com\\\/#website\"},\"datePublished\":\"2022-07-24T23:34:40+00:00\",\"author\":{\"@id\":\"http:\\\/\\\/wmtc2006.com\\\/#\\\/schema\\\/person\\\/5a1d916d8ed9c89b34ac45c96f81e776\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/wmtc2006.com\\\/?p=358#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/wmtc2006.com\\\/?p=358\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/wmtc2006.com\\\/?p=358#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"http:\\\/\\\/wmtc2006.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\ufeffAlthough neither sex nor age were significantly associated with disease outcome in any model for DENV-3, we ran a paired case-control analysis, matching on these variables\"}]},{\"@type\":\"WebSite\",\"@id\":\"http:\\\/\\\/wmtc2006.com\\\/#website\",\"url\":\"http:\\\/\\\/wmtc2006.com\\\/\",\"name\":\"Discovery and characterization of Histamine-2 Receptor Antagonists\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"http:\\\/\\\/wmtc2006.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"http:\\\/\\\/wmtc2006.com\\\/#\\\/schema\\\/person\\\/5a1d916d8ed9c89b34ac45c96f81e776\",\"name\":\"wpadmin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e57206ca88c051844b618224f501afdd8e9328b238000fd2f37bf30c03bcff14?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e57206ca88c051844b618224f501afdd8e9328b238000fd2f37bf30c03bcff14?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e57206ca88c051844b618224f501afdd8e9328b238000fd2f37bf30c03bcff14?s=96&d=mm&r=g\",\"caption\":\"wpadmin\"},\"sameAs\":[\"http:\\\/\\\/wmtc2006.com\"],\"url\":\"https:\\\/\\\/wmtc2006.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\ufeffAlthough neither sex nor age were significantly associated with disease outcome in any model for DENV-3, we ran a paired case-control analysis, matching on these variables - Discovery and characterization of Histamine-2 Receptor Antagonists","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/wmtc2006.com\/?p=358","og_locale":"en_US","og_type":"article","og_title":"\ufeffAlthough neither sex nor age were significantly associated with disease outcome in any model for DENV-3, we ran a paired case-control analysis, matching on these variables - Discovery and characterization of Histamine-2 Receptor Antagonists","og_description":"\ufeffAlthough neither sex nor age were significantly associated with disease outcome in any model for DENV-3, we ran a paired case-control analysis, matching on these [...]","og_url":"https:\/\/wmtc2006.com\/?p=358","og_site_name":"Discovery and characterization of Histamine-2 Receptor Antagonists","article_published_time":"2022-07-24T23:34:40+00:00","author":"wpadmin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"wpadmin","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/wmtc2006.com\/?p=358#article","isPartOf":{"@id":"https:\/\/wmtc2006.com\/?p=358"},"author":{"name":"wpadmin","@id":"http:\/\/wmtc2006.com\/#\/schema\/person\/5a1d916d8ed9c89b34ac45c96f81e776"},"headline":"\ufeffAlthough neither sex nor age were significantly associated with disease outcome in any model for DENV-3, we ran a paired case-control analysis, matching on these variables","datePublished":"2022-07-24T23:34:40+00:00","mainEntityOfPage":{"@id":"https:\/\/wmtc2006.com\/?p=358"},"wordCount":705,"articleSection":["Hydroxytryptamine, 5- Transporters"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/wmtc2006.com\/?p=358","url":"https:\/\/wmtc2006.com\/?p=358","name":"\ufeffAlthough neither sex nor age were significantly associated with disease outcome in any model for DENV-3, we ran a paired case-control analysis, matching on these variables - Discovery and characterization of Histamine-2 Receptor Antagonists","isPartOf":{"@id":"http:\/\/wmtc2006.com\/#website"},"datePublished":"2022-07-24T23:34:40+00:00","author":{"@id":"http:\/\/wmtc2006.com\/#\/schema\/person\/5a1d916d8ed9c89b34ac45c96f81e776"},"breadcrumb":{"@id":"https:\/\/wmtc2006.com\/?p=358#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/wmtc2006.com\/?p=358"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/wmtc2006.com\/?p=358#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"http:\/\/wmtc2006.com\/"},{"@type":"ListItem","position":2,"name":"\ufeffAlthough neither sex nor age were significantly associated with disease outcome in any model for DENV-3, we ran a paired case-control analysis, matching on these variables"}]},{"@type":"WebSite","@id":"http:\/\/wmtc2006.com\/#website","url":"http:\/\/wmtc2006.com\/","name":"Discovery and characterization of Histamine-2 Receptor Antagonists","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"http:\/\/wmtc2006.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"http:\/\/wmtc2006.com\/#\/schema\/person\/5a1d916d8ed9c89b34ac45c96f81e776","name":"wpadmin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/e57206ca88c051844b618224f501afdd8e9328b238000fd2f37bf30c03bcff14?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e57206ca88c051844b618224f501afdd8e9328b238000fd2f37bf30c03bcff14?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e57206ca88c051844b618224f501afdd8e9328b238000fd2f37bf30c03bcff14?s=96&d=mm&r=g","caption":"wpadmin"},"sameAs":["http:\/\/wmtc2006.com"],"url":"https:\/\/wmtc2006.com\/?author=1"}]}},"_links":{"self":[{"href":"https:\/\/wmtc2006.com\/index.php?rest_route=\/wp\/v2\/posts\/358","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wmtc2006.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wmtc2006.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/wmtc2006.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/wmtc2006.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=358"}],"version-history":[{"count":1,"href":"https:\/\/wmtc2006.com\/index.php?rest_route=\/wp\/v2\/posts\/358\/revisions"}],"predecessor-version":[{"id":359,"href":"https:\/\/wmtc2006.com\/index.php?rest_route=\/wp\/v2\/posts\/358\/revisions\/359"}],"wp:attachment":[{"href":"https:\/\/wmtc2006.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=358"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wmtc2006.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=358"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wmtc2006.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=358"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}